Chemodex

9-(Hydroxymethyl)-10-carbamoylacridan

Product Code:
 
CDX-H0118
Product Group:
 
Other Biochemicals
Supplier:
 
Chemodex
Regulatory Status:
 
RUO
Shipping:
 
Ambient
Storage:
 
+4°C
1 / 1
Chemical Structure

Chemical Structure

No additional charges, what you see is what you pay! *

CodeSizePrice
CDX-H0118-M01010 mg£121.00
Quantity:
CDX-H0118-M02525 mg£230.00
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: Switzerland.
Typical lead time: 7-10 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Alternate Names/Synonyms:
9-HMCA; 9-OH-CBZ; 9-(Hydroxymethyl)-10(9H)-acridinecarboxamide
Appearance:
White powder.
CAS:
68011-71-2
EClass:
32160000
Form (Short):
liquid
Handling Advice:
Keep cool and dry.Protect from light and moisture.
InChi:
InChI=1S/C15H14N2O2/c16-15(19)17-13-7-3-1-5-10(13)12(9-18)11-6-2-4-8-14(11)17/h1-8,12,18H,9H2,(H2,16,19)
InChiKey:
LAUDUHYRZXCAJM-UHFFFAOYSA-N
Long Description:
Chemical. CAS: 68011-71-2. Formula: C15H14N2O2. MW: 254.28. Synthetic Major intermediate in carbamazepine metabolism. This carbamazepine metabolite can be used as a reference compound.
MDL:
MFCD02656423
Molecular Formula:
C15H14N2O2
Molecular Weight:
254.28
Package Type:
Vial
Product Description:
Major intermediate in carbamazepine metabolism. This carbamazepine metabolite can be used as a reference compound.
Purity:
>98% (HPLC)
SMILES:
NC(=O)N1C2=CC=CC=C2C(CO)C2=C1C=CC=C2
Solubility Chemicals:
Soluble in THF and chloroform.
Source / Host:
Synthetic
Transportation:
Non-hazardous
UNSPSC Category:
Biochemical Reagents
UNSPSC Number:
12352200
Use & Stability:
Stable for at least 2 years after receipt when stored at -20°C.

References

(1) S. Eto, et al.; Biol. Pharm. Bull. 18, 926 (1995) | (2) N. Wad, et al.; Ther. Drug Monit. 19, 314 (1997) | (3) A. Bahlmann, et al.; Water Res. 57, 104 (2014)